Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

BACKGROUND: The combination of sofosbuvir (SOF), ribavirin (RBV) and peg-interferon-alfa-2a (peg-IFN-alfa-2a) as well as the combination of SOF and RBV for the treatment of patients infected with hepatitis c virus (HCV) has improved rates of sustained virological response (SVR) considerably in recen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Steinebrunner, Niels, Sprinzl, Martin F., Zimmermann, Tim, Wörns, Marcus A., Zimmerer, Thomas, Galle, Peter R., Stremmel, Wolfgang, Eisenbach, Christoph, Stein, Kerstin, Antoni, Christoph, Schattenberg, Jörn M., Pathil, Anita
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4523924/
https://ncbi.nlm.nih.gov/pubmed/26239732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0328-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados